Waters and Sartorius integrate BioAccord LC-MS system with Ambr to accelerate bioprocess development

Written by Campbell Brooks

Waters Corporation (MA, USA) and Sartorius AG (Göttingen, Germany) announced that they have agreed a partnership to integrate the Waters™ BioAccord™ LC–MS System and Sartorius’ Ambr® bioreactor in the hope that the connected system will accelerate process development for scientists in the rapidly expanding biopharmaceutical industry. Ambr is a popular high-throughput automated microbioreactor, often utilized to iterate and optimize cell culture parameters with the aim of developing successful biopharmaceuticals. At the completion of the cell culture process, analytes of interest are separated from the cell residue and samples are often sent for analysis by a central laboratory, a process that...

To view this content, please register now for access

It's completely free